Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates.

[1]  G. Kearns.  Selecting the proper pediatric dose: It is more than size that matters , 2015, Clinical pharmacology and therapeutics.

[2]  M. Laughon,et al.  Mechanisms to Provide Safe and Effective Drugs for Children , 2014, Pediatrics.

[3]  B. Poindexter,et al.  Characterization of the Population Pharmacokinetics of Ampicillin in Neonates Using an Opportunistic Study Design , 2014, Antimicrobial Agents and Chemotherapy.

[4]  M. Laughon,et al.  Medication Use in the Neonatal Intensive Care Unit , 2013, American Journal of Perinatology.

[5]  A. Herring,et al.  Adverse Events Associated With Meropenem Versus Imipenem/Cilastatin Therapy in a Large Retrospective Cohort of Hospitalized Infants , 2013, The Pediatric infectious disease journal.

[6]  B. Poindexter,et al.  Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  T. Metsvaht,et al.  Ampicillin versus penicillin in the empiric therapy of extremely low‐birthweight neonates at risk of early onset sepsis , 2011, Pediatrics international : official journal of the Japan Pediatric Society.

[8]  W. Rodriguez,et al.  Extrapolation of Adult Data and Other Data in Pediatric Drug-Development Programs , 2011, Pediatrics.

[9]  B. Poindexter,et al.  Population Pharmacokinetics of Meropenem in Plasma and Cerebrospinal Fluid of Infants With Suspected or Complicated Intra-abdominal Infections , 2011, The Pediatric infectious disease journal.

[10]  M. Laughon,et al.  Innovative clinical trial design for pediatric therapeutics , 2011, Expert review of clinical pharmacology.

[11]  T. Metsvaht,et al.  Comparison of ampicillin plus gentamicin vs. penicillin plus gentamicin in empiric treatment of neonates at risk of early onset sepsis , 2010, Acta paediatrica.

[12]  A. Spitzer,et al.  The Pediatrix BabySteps Data Warehouse and the Pediatrix QualitySteps improvement project system--tools for "meaningful use" in continuous quality improvement. , 2010, Clinics in perinatology.

[13]  B. Stoll,et al.  Very Low Birth Weight Preterm Infants With Early Onset Neonatal Sepsis: The Predominance of Gram-Negative Infections Continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002–2003 , 2005, The Pediatric infectious disease journal.

[14]  P. Gal,et al.  Ampicillin-Induced Neurotoxicity in Very-Low-Birth-Weight Neonates , 1998, The Annals of pharmacotherapy.

[15]  J. Tyson,et al.  Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. , 1996, The Journal of pediatrics.

[16]  R. Barrons,et al.  Populations at Risk for Penicillin-Induced Seizures , 1992, The Annals of pharmacotherapy.

[17]  J. Dasta,et al.  Ampicillin-associated seizures. , 1984, Southern medical journal.

[18]  M. Serdaru,et al.  GENERALISED SEIZURES AND AMPICILLIN , 1982, The Lancet.

[19]  G. Mccracken,et al.  Pharmacologic studies in neonates given large dosages of ampicillin. , 1974, The Journal of pediatrics.

[20]  J. Bennett,et al.  Serum levels of methicillin and ampicillin in newborn and premature infants in relation to postnatal age. , 1967, Pediatrics.

[21]  S. G. Axline,et al.  Clinical pharmacology of antimicrobials in premature infants. II. Ampicillin, methicillin, oxacillin, neomycin, and colistin. , 1967, Pediatrics.

[22]  J. F. Brown,et al.  H. Influenzæ Meningitis: A Controlled Study of Treatment with Ampicillin , 1964, Postgraduate medical journal.

[23]  Branden M. Engorn,et al.  The Harriet Lane handbook : a manual for pediatric house officers , 2015 .

[24]  L. Kux.  OF HEALTH AND HUMAN SERVICES Food and Drug Administration , 2014 .

[25]  P. Toltzis.  Empiric Use of Ampicillin and Cefotaxime, Compared With Ampicillin and Gentamicin, for Neonates at Risk for Sepsis Is Associated With an Increased Risk of Neonatal Death , 2007 .

[26]  R. Barrons,et al.  POPULATIONS AT RISKFORPENICILLIN-INDUCED SEIZURES , 1992 .

[27]  P. Morselli.  Clinical Pharmacology of the Perinatal Period and Early Infancy , 1989, Clinical pharmacokinetics.